Building Medical Affairs Teams of The Future: A Strategic Advantage in the Age of Data Driven Health

October 14, 2020 8:00 AM - 9:00 AM

Webinar, click "live-stream" button to view

Add to Calendar 10/14/2020 8:00:16 AM 10/14/2020 9:00:16 AM Building Medical Affairs Teams of The Future: A Strategic Advantage in the Age of Data Driven Health

Medical Affairs was created as a support function to marketing and sales but has evolved over the last decade into the third pillar of pharmaceutical and biotechnology companies. Today, with the breadth and depth of diverse data sources, rapid changes in technology, increasing scientific complexity of treatments, and regulatory and economic trends, organizations that cultivate strategic and diversely talented medical teams have the competitive advantage.

Forward looking organizations are building the medical affairs teams of the future. These teams are breaking down traditional silos and developing capacities to evolve data generation across clinical development, HEOR and real-world evidence. They are evolving to effectively translate, not only the clinical, but also the economic impact to increasingly important stakeholders, especially payer decision-makers with unprecedented size and scale and knowledge-empowered patients.

In a day of rapid scientific and medical advancement, equity, and economic concerns, the pharmaceutical industry requires strategic medical leadership. Required are highly skilled and empowered medical affairs teams that harness data and insights to help physicians, payers, and patients choose the right medication, at the right time, to drive meaningful impact for individual patients and societal health outcomes.

Join us for an overview from McKinsey of how medical affairs has evolved over time and where it is headed followed by a panel discussion on how life sciences companies of all sizes can best hire, develop, and leverage these skilled professionals for a competitive advantage.

Sponsored by the MassBio MarCom and Commercial Forum Working Group.

MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.
 

Webinar, click "live-stream" button to view

Medical Affairs was created as a support function to marketing and sales but has evolved over the last decade into the third pillar of pharmaceutical and biotechnology companies. Today, with the breadth and depth of diverse data sources, rapid changes in technology, increasing scientific complexity of treatments, and regulatory and economic trends, organizations that cultivate strategic and diversely talented medical teams have the competitive advantage.

Forward looking organizations are building the medical affairs teams of the future. These teams are breaking down traditional silos and developing capacities to evolve data generation across clinical development, HEOR and real-world evidence. They are evolving to effectively translate, not only the clinical, but also the economic impact to increasingly important stakeholders, especially payer decision-makers with unprecedented size and scale and knowledge-empowered patients.

In a day of rapid scientific and medical advancement, equity, and economic concerns, the pharmaceutical industry requires strategic medical leadership. Required are highly skilled and empowered medical affairs teams that harness data and insights to help physicians, payers, and patients choose the right medication, at the right time, to drive meaningful impact for individual patients and societal health outcomes.

Join us for an overview from McKinsey of how medical affairs has evolved over time and where it is headed followed by a panel discussion on how life sciences companies of all sizes can best hire, develop, and leverage these skilled professionals for a competitive advantage.

Sponsored by the MassBio MarCom and Commercial Forum Working Group.

MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.
 

Director, Health Economics and Outcomes Research, US, Takeda
Marie is a biopharma professional and PhD immunologist with over 15 years of biopharmaceutical experience in complex specialty drug care. Marie currently works as Director of Outcomes Research at Takeda Pharmaceuticals. Prior to Takeda, Marie worked in national medical access roles at Sanofi Genzyme and Intercept Pharmaceuticals, helping create access with both national US payers and PBMs for 7 drug launches. Before joining the pharmaceutical industry, Marie was an associate professor at UMASS Medical School and Instructor of Medicine at Harvard Medical School. Marie received her bachelor’s degree in biochemistry at Ithaca College, her PhD from UMASS, Amherst and specialty trained in immunology as an NIH postdoctoral fellow and Instructor of medicine at Harvard Medical school/Dana Farber Cancer Institute. Marie has three teenage daughters (ages 19, 17 and 13), is a dedicated hot yogi and outdoor enthusiast and was once pulled over for speeding on a jet ski.